LS CANCERDIAG OY

LS CancerDiag Ltd is committed to reducing cancer mortality rates with an efficient, simple diagnostic method that detects an inherited cancer-causing condition prior to cancer. Their vision is to see DiagMMR™ as a new global testing standard in LS diagnostics. Lynch syndrome is the main cause of hereditary colorectal cancers and it also causes a broad spectrum of other tumors. With a significant proportion of the world’s population carrying the Lynch syndrome mutation, there are potentiall... y tens of millions under a severe risk for being affected by LS. Their groundbreaking DiagMMR™ assay is an easy functional test that can be used for diagnosis of MMR deficiency i.e. Lynch syndrome (previously known as Hereditary NonPolyposis Colorectal Cancer; HNPCC). Their mission is to save lives through an innovation that dramatically simplifies diagnostics of Lynch syndrome by delivering predictive and accurate results with a fast, unique and cost-efficient method globally.

#SimilarOrganizations #People #Financial #Website #More

LS CANCERDIAG OY

Social Links:

Facebook

Twitter

Industry:

Bioinformatics Health Care Health Diagnostics

Founded:

2013-01-01

Address:

Helsinki, Southern Finland, Finland

Country:

Finland

Website Url:

http://www.lscancerdiag.com

Total Employee:

Status:

Active

Email Addresses:

[email protected]

Total Funding:

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Font Awesome